Pre- and postnatal brain development in neonates with congenital hypothyroidism

Area of Science:

• Pediatrics
• Endocrinology
• Neurodevelopmental Disorders

Background:

• Congenital hypothyroidism (CH) can lead to subnormal development and neurological defects in children.
• The effectiveness of optimal treatment in preventing these abnormalities, especially in severe CH cases, remains a critical question.

Purpose of the Study:

• To investigate the impact of early and high-dose levothyroxine treatment on psychomotor development in infants with congenital hypothyroidism.
• To determine if optimal treatment can fully prevent neurological abnormalities associated with CH.

Main Methods:

• The study involved 61 infants (27 severe, 34 mild CH) aged 10-30 months, assessed using the Bayley Scales of Infant Development.
• Patients were categorized into four groups based on treatment initiation (Early/Late) and levothyroxine dosage (High/Low).
• Somatosensory evoked potentials (SEP) were used in a subset of 21 infants to assess neurological maturation.

Main Results:

• Early and high-dose levothyroxine treatment led to normal developmental scores in infants with severe CH.
• Infants with mild CH treated late and with a low dose exhibited lower developmental scores.
• SEP and bone age correlations at 12 months suggested that late and inadequate treatment, rather than prenatal deficiency, influenced neurological maturation.

Conclusions:

• Early and high-dose levothyroxine administration is crucial for achieving normal psychomotor development in infants with CH, irrespective of CH severity.
• Late and low-dose treatment is associated with suboptimal neurodevelopmental outcomes.
• Intervention timing and dosage are critical factors in mitigating the long-term effects of CH on brain development.